申请人:Nahra Joe
公开号:US20090137637A1
公开(公告)日:2009-05-28
This invention relates to a compound of Formula (I) or a pharmaceutically acceptable salt thereof; a pharmaceutical composition; a method of treating a disease mediated by an MMP-13 enzyme in a mammal; and a therapeutic combination containing at least two pharmaceutically active components, wherein R
1
, Q, W
1
, W
2
, R
2a
, L
1
, and R
3
, the pharmaceutical composition, the method of treating, and the therapeutic combination are as defined in the specification.
本发明涉及公式(I)的化合物或其药学上可接受的盐;一种制药组合物;一种治疗哺乳动物中由MMP-13酶介导的疾病的方法;以及至少包含两种药理活性成分的治疗组合物,其中R1、Q、W1、W2、R2a、L1和R3、制药组合物、治疗方法和治疗组合物的定义如说明书所述。